Blueberry Therapeutics

Early stage

Blueberry Therapeutics is a biotechnology company developing a range of anti-microbial products using a proprietary drug delivery technology. It's lead product is an innovative treatment for fungal nail infection (onychomycosis).

We were attracted to Blueberry by the exceptional experience of its management team and their compelling preclinical data for this well differentiated and novel topical treatment for fungal nail infections.

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Corinne Lawrence

view complete team

Contact us

Tel: 01625 344300